Skip to content

Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care

Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04994457
Enrollment
287
Registered
2021-08-06
Start date
2021-10-30
Completion date
2024-06-21
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

Visual Field, Virtual Reality

Brief summary

The purpose of this research is to study the effectiveness and patient experience when measuring visual fields using virtual reality goggles.

Interventions

DEVICEVirtual Reality Visual Field

A head-mounted perimeter with a wireless remote connected to a laptop that monitors responses

DIAGNOSTIC_TESTStandard Automated Perimetry

Standard of care perimeter

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion: * Any individual who is physically able to take a virtual reality visual field test * Patients who either have glaucoma, are glaucoma suspects, or have a strong family history of glaucoma, or have other visual field defects, and normal individual * Age: Individuals who are old enough to comprehend the instructions and procedures (1-90) Exclusion: * Adults unable to consent, prisoners * Participants who are too tired to take a visual field test * Participants who refuse to consent * Individuals who are functionally unable to use VRVF

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of VRVF compared to SAPDay 1Sensitivity of VRVF will be determined by comparing Hodapp Anderson Parrish (HAP) Scores, which assess the severity of visual field defects, to those of SAP
Specificity of VRVF compared to SAPDay 1Specificity of VRVF will be determined by comparing Hodapp Anderson Parrish (HAP) Scores, which assess the severity of visual field defects, to those of SAP

Secondary

MeasureTime frameDescription
Variability of Mean DeviationDay 1Variability of the mean deviation scores obtained from VRVF and SAP

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026